Have a personal or library account? Click to login
Intravenous Rh immune globulin prevents alloimmunization in D– granulocyte recipients but obscures the detection of an alloanti-K Cover

Intravenous Rh immune globulin prevents alloimmunization in D– granulocyte recipients but obscures the detection of an alloanti-K

Paid access
|Oct 2020

References

  1. DePalma L, Leitman SF, Carter CS, Gallin JI. Granulocyte transfusion therapy in a child with chronic granulomatous disease and multiple RBC antibodies. Transfusion 1989; 29: 4213.10.1046/j.1537-2995.1989.29589284143.x
  2. Vengelen-Tyler V, ed. Technical manual. 13th ed. Bethesda, MD: American Association of Blood Banks, 1999: 458.
  3. Rosse WF, Gallagher D, Kinny TR, et al. Transfusion and alloimmunization in sickle cell disease. The cooperative study of sickle cell disease. Blood 1990;76:14317.10.1182/blood.V76.7.1431.1431
  4. Pollack W, Gorman JG, Freda, VJ, et al. Results of clinical trials of RhoGAM in women. Transfusion 1968;8:1513.10.1111/j.1537-2995.1968.tb04895.x
  5. Bowman JM, Albert D, Friesen M, Pollock JM, Taylor WE. WinRho: Rh immune globulin prepared by ion exchange for intravenous use. CMA Journal 1980;123:11215.
  6. Ennker J, Maas DHA, Schneider J. Immuno-prophylatic anti-Rho(D) treatment after mismatched transfusions. Eur J Obstet Gynecol Reprod Biol 1979; 9:11724.10.1016/0028-2243(79)90009-1
  7. Bowman HS. Effectiveness of prophylatic Rh immunosuppression after transfusion with D-positive blood. Am J Obstet Gynecol 1976; 124: 80–4.10.1016/0002-9378(76)90015-6
  8. Hartwell EA. Use of Rh immune globulin. ASCP practice parameter. Am J Clin Pathol 1998; 100: 28192.
  9. Zeiler T, Wittmann G, Zingsem J, Weisbach V, Zimmerman R, Eckstein R. A dose of 100 IU intravenous anti-D gamma globulin is effective for the prevention of RhD immunization after RhD-incompatible single donor platelet transfusion. Vox Sang 1994; 66:243.
  10. Jouvenceaux A, Adenot N., Berthoux F, Revol L. Gamma-globuline anti-D lyophilisée intra-veineuse pour la prévention de l’immunisation anti-Rh. Rev Franc Transfus 1969; 13 (Suppl 1):341.10.1016/S0035-2977(68)80023-9
  11. Anderson B, Shad AT, Gootenberg JE, Sandler SG. Successful prevention of posttransfusion Rh alloimmunization by intravenous Rho (D) immune globulin (WinRho SD). Am J Hematol 1999; 60: 2457.10.1002/(SICI)1096-8652(199903)60:3<;245::AID-AJH16>3.0.CO;2-4
  12. Kupferman MJ, Cipolone KM, Procter JL, Stroncek DF. Comparison of tube and gel red cell agglutination techniques in detecting chimeras after a major ABO-mismatched allogeneic hematopoietic stem cell transplantation. Immunohematology 1998; 14: 6871.10.21307/immunohematology-2019-662
  13. Bowman, JM. The advantages of intravenous Rh-immune globulin. Clin Obstet Gynecol 1982; 25:3417.10.1097/00003081-198206000-00014
  14. Mollison PL, Engelfriet LJ, Contreras M, eds. Blood transfusion in clinical medicine. 9th ed. Boston, MA: Blackwell Science, 1993:2412.
  15. Wright J, Freedman J, Lim FC, Garvey MB. Crossmatch difficulties following the prophylactic use of Rh immune globulin. Can Med Assoc J 1979; 120: 12358.
DOI: https://doi.org/10.21307/immunohematology-2019-541 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 37 - 41
Published on: Oct 14, 2020
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 D.F. Stroncek, J. L. Procter, L. Moses, C. Bolan, G.J. Pomper, C. Conroy-Cantilena, H.L. Malech, H.G. Klein, S.F. Leitman, published by American National Red Cross
This work is licensed under the Creative Commons License.